| Title | GaBI Journal |
| Abbreviation | GaBI J. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacy (Q3); Drug Guides (Q4) |
| h-index | 15 |
| Overall Rank/Ranking | 20533 |
| SCImago Journal Rank (SJR) | 0.174 |
| Impact Score | 0.68 |
| Publisher | Pro Pharma Communications International |
| Country | Belgium |
| ISSN | 20336403, 20336772 |
| Best Quartile | Q3 |
| Coverage History | 2014-2020 |
GaBI Journal is a journal covering the technologies/fields/categories related to Pharmacy (Q3); Drug Guides (Q4). It is published by Pro Pharma Communications International. The overall rank of GaBI Journal is 20533. According to SCImago Journal Rank (SJR), this journal is ranked 0.174. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 15. The best quartile for this journal is Q3.
The ISSN of GaBI Journal journal is 20336403, 20336772. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. GaBI Journal is cited by a total of 30 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of GaBI Journal is 0.68, which is computed in 2023 as per its definition. GaBI Journal IF is decreased by a factor of 0.1 and approximate percentage change is -12.82% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of GaBI Journal is 0.68. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.68 |
| 2021 | 0.78 |
| 2020 | 1.02 |
| 2019 | 0.78 |
| 2018 | 0.74 |
| 2017 | 0.87 |
| 2016 | 0.78 |
| 2015 | 0.93 |
| 2014 | 0.00 |
GaBI Journal has an h-index of 15. It means 15 articles of this journal have more than 15 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of GaBI Journal is 20336403, 20336772. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of GaBI Journal is 20533. According to SCImago Journal Rank (SJR), this journal is ranked 0.174. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.174 |
| 2021 | 0.153 |
| 2020 | 0.217 |
| 2019 | 0.167 |
| 2018 | 0.297 |
| 2017 | 0.479 |
| 2016 | 0.399 |
| 2015 | 0.413 |
| 2014 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 20533 |
| 2021 | 20971 |
| 2020 | 18308 |
| 2019 | 20547 |
| 2018 | 13815 |
| 2017 | 9540 |
| 2016 | 11042 |
| 2015 | 10659 |
| 2014 | 31892 |
GaBI Journal is published by Pro Pharma Communications International. It's publishing house is located in Belgium. Coverage history of this journal is as following: 2014-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of GaBI Journal is GaBI J.. This abbreviation ('GaBI J.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacy (Q3); Drug Guides (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
GaBI Journal latest impact IF is 0.68. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.02 (2020) and 0.00 (2014), respectively, in the last 9 years. Moreover, its average IS is 0.73 in the previous 9 years.
The GaBI Journal has an SJR (SCImago Journal Rank) of 0.174, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.479 in 2017 and the lowest being in 2014. Furthermore, the average SJR of the GaBI Journal over the previous 9-year period stands at 0.73.
The latest h-index of the GaBI Journal is 15.
The GaBI Journal is published by the Pro Pharma Communications International, with its country of publication being the Belgium.
The GaBI Journal is currently ranked 20533 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 9540 in 2017 and its lowest position of 31892 in 2014.
The standard ISO4 abbreviation for the GaBI Journal is GaBI J..
GaBI Journal is classified as a journal that the Pro Pharma Communications International publishes.
The GaBI Journal encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The GaBI Journal is assigned the following International Standard Serial Numbers (ISSN): 20336403, 20336772.
The best quartile for the GaBI Journal is Q3 (2022).
The GaBI Journal coverage history can be summarized as follows: 2014-2020.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8920 | Springer Netherlands | 26 | 2.28 |
| Milan Journal of Mathematics | journal | 3120 | Birkhauser Verlag Basel | 28 | 1.79 |
| Mathematical Modelling and Analysis | journal | 11315 | Vilnius Gediminas Technical University | 27 | 1.75 |
| Discourse | journal | 6621 | Routledge | 59 | 2.11 |
| Abacus | journal | 8398 | Wiley-Blackwell Publishing Ltd | 49 | 2.52 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Tekstilec | trade journal | 19217 | Faculty of Natural Sciences and Engineering, Tekstilec | 14 | 0.73 |
| Sapporo Medical Journal | journal | 20468 | Cancer Research Institute, Sapporo Medical University | 3 | 0.00 |
| Acta Periodica Technologica | journal | 19470 | University of Novi Sad, Faculty of Technology | 18 | 0.62 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.68 |
| 2021 | 0.78 |
| 2020 | 1.02 |
| 2019 | 0.78 |
| 2018 | 0.74 |
| 2017 | 0.87 |
| 2016 | 0.78 |
| 2015 | 0.93 |
| 2014 | 0.00 |
